N-acetylserotonin alleviates retinal ischemia-reperfusion injury via HMGB1/RAGE/NF-κB pathway in rats
Author:
Corresponding Author:

Yan-Song Zhao. Department of Ophthalmology, Affiliated Hospital of Weifang Medical University, Weifang 261031, Shandong Province, China. zhaoyansong74@163.com; Xiao-Li Wang. School of Medical Imaging, Weifang Medical University, Weifang 261053, Shandong Province, China. wxlpine@163.com; Shu-Na Yu. Department of Anatomy, Weifang Medical University, Weifang 261053, Shandong Province, China. yushn@126.com

Fund Project:

Supported by the National Natural Science Foundation of China (No.82071888); the Natural Science Foundation of Shandong Province (No.ZR2021MH351; No.ZR2020MH074); the Introduction and Cultivation Project for Young Innovative Talents in Shandong Province; Weifang Science and Technology Development Plan (No.2021GX057).

  • Article
  • | |
  • Metrics
  • |
  • Reference [44]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    AIM: To observe the effects of N-acetylserotonin (NAS) administration on retinal ischemia-reperfusion (RIR) injury in rats and explore the underlying mechanisms involving the high mobility group box 1 (HMGB1)/receptor for advanced glycation end-products (RAGE)/nuclear factor-kappa B (NF-κB) signaling pathway. METHODS: A rat model of RIR was developed by increasing the pressure of the anterior chamber of the eye. Eighty male Sprague Dawley were randomly divided into five groups: sham group (n=8), RIR group (n=28), RIR+NAS group (n=28), RIR+FPS-ZM1 group (n=8) and RIR+NAS+ FPS-ZM1 group (n=8). The therapeutic effects of NAS were examined by hematoxylin-eosin (H&E) staining, and retinal ganglion cells (RGCs) counting. The expression of interleukin 1 beta (IL-1β), HMGB1, RAGE, and nod-like receptor 3 (NLRP3) proteins and the phosphorylation of nuclear factor-kappa B (p-NF-κB) were analyzed by immunohistochemistry staining and Western blot analysis. The expression of HMGB1 protein was also detected by enzyme-linked immunosorbent assay (ELISA). RESULTS: H&E staining results showed that NAS significantly reduced retinal edema and increased the number of RGCs in RIR rats. With NAS therapy, the HMGB1 and RAGE expression decreased significantly, and the activation of the NF-κB/NLRP3 pathway was antagonized along with the inhibition of p-NF-κB and NLRP3 protein expression. Additionally, NAS exhibited an anti-inflammatory effect by reducing IL-1β expression. The inhibitory of RAGE binding to HMGB1 by RAGE inhibitor FPS-ZM1 led to a significant decrease of p-NF-κB and NLRP3 expression, so as to the IL-1β expression and retinal edema, accompanied by an increase of RGCs in RIR rats. CONCLUSION: NAS may exhibit a neuroprotective effect against RIR via the HMGB1/RAGE/NF-κB signaling pathway, which may be a useful therapeutic target for retinal disease.

    Reference
    1 Han LH, Zhang ML, Yang ZZ, Diao K, Jia X, Li MR, Tian GQ. Huoxue-Tongluo-Lishui-Decoction is visual-protective against retinal ischemia-reperfusion injury. Biomed Pharmacother 2020;125:109998.
    2 Chen Z, Qiu PY, Ma CG. Dexmedetomidine preconditioning protects against retinal ischemia/reperfusion injury and inhibits inflammation response via toll-like receptor 4 (TLR4) pathway. Biomed Pharmacother 2017;93:1018-1024.
    3 Jiang N, Li ZD, Li ZH, Zhang YY, Yu ZY, Wan PX, Zhu YT, Li YQ, Su WR, Zhuo YH. Laquinimod exerts anti-inflammatory and antiapoptotic effects in retinal ischemia/reperfusion injury. Int Immunopharmacol 2020;88:106989.
    4 Wan PX, Su WR, Zhang YY, Li ZD, Deng CB, Li JM, Jiang N, Huang SY, Long EP, Zhuo YH. LncRNA H19 initiates microglial pyroptosis and neuronal death in retinal ischemia/reperfusion injury. Cell Death Differ 2020;27(1):176-191.
    5 Osborne NN, Casson RJ, Wood JPM, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 2004;23(1):91-147.
    6 Minhas G, Sharma J, Khan N. Cellular stress response and immune signaling in retinal ischemia-reperfusion injury. Front Immunol 2016;7:444.
    7 Mahaling B, Low SWY, Beck M, Kumar D, Ahmed S, Connor TB, Ahmad B, Chaurasia SS. Damage-associated molecular patterns (DAMPs) in retinal disorders. Int J Mol Sci 2022;23(5):2591.
    8 Dvoriantchikova G, Hernandez E, Grant J, Santos ARC, Yang H, Ivanov D. The high-mobility group box-1 nuclear factor mediates retinal injury after ischemia reperfusion. Invest Ophthalmol Vis Sci 2011;52(10):7187-7194.
    9 Mi L, Zhang Y, Xu YG, Zheng X, Zhang X, Wang Z, Xue M, Jin X. HMGB1/RAGE pro-inflammatory axis promotes vascular endothelial cell apoptosis in limb ischemia/reperfusion injury. Biomed Pharmacother 2019;116:109005.
    10 Steinle JJ. Role of HMGB1 signaling in the inflammatory process in diabetic retinopathy. Cell Signal 2020;73:109687.
    11 Kelley N, Jeltema D, Duan YH, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci 2019;20(13):3328.
    12 Hangai M, Yoshimura N, Yoshida M, Yabuuchi K, Honda Y. Interleukin-1 gene expression in transient retinal ischemia in the rat. Invest Ophthalmol Vis Sci 1995;36(3):571-578.
    13 Lezoualc’h F, Sparapani M, Behl C. N-acetyl-serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF-kappaB. J Pineal Res 1998;24(3):168-178.
    14 Luo CL, Yang Q, Liu YC, Zhou SH, Jiang JY, Reiter RJ, Bhattacharya P, Cui YC, Yang HW, Ma H, Yao JM, Lawler SE, Zhang XM, Fu JF, Rozental R, Aly H, Johnson MD, Chiocca EA, Wang X. The multiple protective roles and molecular mechanisms of melatonin and its precursor N-acetylserotonin in targeting brain injury and liver damage and in maintaining bone health. Free Radic Biol Med 2019;130:215-233.
    15 Rui TY, Wang ZF, Li QQ, Wang HC, Wang T, Zhang MY, Tao LY, Luo CL. A TrkB receptor agonist N-acetyl serotonin provides cerebral protection after traumatic brain injury by mitigating apoptotic activation and autophagic dysfunction. Neurochem Int 2020;132:104606.
    16 Yu SN, Zheng J, Jiang ZC, Shi CX, Li J, Du XD, Wang HL, Jiang JY, Wang X. Protective effect of N-acetylserotonin against acute hepatic ischemia-reperfusion injury in mice. Int J Mol Sci 2013;14(9): 17680-17693.
    17 Sukhotnik I, Ben Shahar Y, Halabi S, Bitterman N, Dorfman T, Pollak Y, Coran A, Bitterman A. Effect of N-acetylserotonin on TLR-4 and MyD88 expression during intestinal ischemia-reperfusion in a rat model. Eur J Pediatr Surg 2019;29(2):188-195.
    18 Luo X, Zeng HL, Fang CZ, Zhang BH. N-acetylserotonin derivative exerts a neuroprotective effect by inhibiting the NLRP3 inflammasome and activating the PI3K/akt/Nrf2 pathway in the model of hypoxic-ischemic brain damage. Neurochem Res 2021;46(2):337-348.
    19 Liu JX, Zhang N, Zhang MB, Yin HW, Zhang XN, Wang X, Wang XL, Zhao YS. N-acetylserotonin alleviated the expression of interleukin-1β in retinal ischemia-reperfusion rats via the TLR4/NF-κB/NLRP3 pathway. Exp Eye Res 2021;208:108595.
    20 Yu AH, Wang S, Xing YQ, Han MY, Shao K. 7, 8-Dihydroxyflavone alleviates apoptosis and inflammation induced by retinal ischemia-reperfusion injury via activating TrkB/Akt/NF-kB signaling pathway. Int J Med Sci 2022;19(1):13-24.
    21 Chen S, Sun YY, Li F, Zhang XY, Hu XY, Zhao XY, Li YX, Li H, Zhang JL, Liu WL, Zheng GQ, Jin XC. Modulation of α7nAchR by melatonin alleviates ischemia and reperfusion-compromised integrity of blood-brain barrier through inhibiting HMGB1-mediated microglia activation and CRTC1-mediated neuronal loss. Cell Mol Neurobiol 2022;42(7):2407-2422.
    22 Zhu FM, Chong Lee Shin OL, Xu HZ, Zhao Z, Pei GC, Hu ZZ, Yang J, Guo YC, Mou JY, Sun J, Zhu H, Wang YX, Wang M, Yang Q, Liao WH, Xu G, Zeng R, Yao Y. Melatonin promoted renal regeneration in folic acid-induced acute kidney injury via inhibiting nucleocytoplasmic translocation of HMGB1 in tubular epithelial cells. Am J Transl Res 2017;9(4):1694-1707.
    23 Kang JW, Koh EJ, Lee SM. Melatonin protects liver against ischemia and reperfusion injury through inhibition of toll-like receptor signaling pathway. J Pineal Res 2011;50(4):403-411.
    24 Ali T, Badshah H, Kim TH, Kim MO. Melatonin attenuates D-galactose-induced memory impairment, neuroinflammation and neurodegeneration via RAGE/NF-K B/JNK signaling pathway in aging mouse model. J Pineal Res 2015;58(1):71-85.
    25 Liu JX, Yin HW, Chen W, Xu N, Yang M, Wang XL, Zhao YS. Effects of different doses of NAS on retinal apoptosis in rats with retinal ischemia-reperfusion injury. Rec Adv Ophthalmol 2019;39(8):728-731,736.
    26 Shen LL, Zhang TY, Yang Y, Lu D, Xu AD, Li KS. FPS-ZM1 alleviates neuroinflammation in focal cerebral ischemia rats via blocking ligand/RAGE/DIAPH1 pathway. ACS Chem Neurosci 2021;12(1):63-78.
    27 Büchi ER, Suivaizdis I, Fu J. Pressure-induced retinal ischemia in rats: an experimental model for quantitative study. Ophthalmologica 1991;203(3):138-147.
    28 Seong H, Jeong JY, Ryu J, Park J, Han YS, Cho HK, Kim SJ, Park JM, Kang SS, Seo SW. Resveratrol prevents hypoxia-induced retinal ganglion cell death related with ErbB2. Int J Ophthalmol 2022;15(3):394-400.
    29 Wang XR, Wu YY. Protective effects of autophagy inhibitor 3-methyladenine on ischemia-reperfusion-induced retinal injury. Int Ophthalmol 2020;40(5):1095-1101.
    30 Tong NT, Zhang ZZ, Zhang W, Qiu YT, Gong YY, Yin LL, Qiu QH, Wu XW. Diosmin alleviates retinal edema by protecting the blood-retinal barrier and reducing retinal vascular permeability during ischemia/reperfusion injury. PLoS One 2013;8(4):e61794.
    31 Iuvone PM, Boatright JH, Tosini G, Ye KQ. N-acetylserotonin: circadian activation of the BDNF receptor and neuroprotection in the retina and brain. Adv Exp Med Biol 2014;801:765-771.
    32 Vasey C, McBride J, Penta K. Circadian rhythm dysregulation and restoration: the role of melatonin. Nutrients 2021;13(10):3480.
    33 Kang JH, Guo XD, Wang YD, Kang XW. Neuroprotective effects of N-acetylserotonin and its derivative. Neuroscience 2023;517:18-25.
    34 Wölfler A, Abuja PM, Schauenstein K, Liebmann PM. N-acetylserotonin is a better extra- and intracellular antioxidant than melatonin. FEBS Lett 1999;449(2-3):206-210.
    35 Vašíček O, Lojek A, Číž M. Serotonin and its metabolites reduce oxidative stress in murine RAW264.7 macrophages and prevent inflammation. J Physiol Biochem 2020;76(1):49-60.
    36 Chen XL, Zhang XD, Li YY, Chen XM, Tang DR, Ran RJ. Involvement of HMGB1 mediated signalling pathway in diabetic retinopathy: evidence from type 2 diabetic rats and ARPE-19 cells under diabetic condition. Br J Ophthalmol 2013;97(12):1598-1603.
    37 Chen XD, Zhang JY, Kim B, Jaitpal S, Meng SS, Adjepong K, Imamura S, Wake H, Nishibori M, Stopa EG, Stonestreet BS. High-mobility group box-1 translocation and release after hypoxic ischemic brain injury in neonatal rats. Exp Neurol 2019;311:1-14.
    38 Kim HJ, Jeong MS, Jang SB. Molecular characteristics of RAGE and advances in small-molecule inhibitors. Int J Mol Sci 2021;22(13):6904.
    39 Tóbon-Velasco JC, Cuevas E, Torres-Ramos MA. Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress. CNS Neurol Disord Drug Targets 2014;13(9):1615-1626.
    40 Zhong X, Liu MY, Yao WF, Du K, He M, Jin X, Jiao LC, Ma GW, Wei BB, Wei MJ. Epigallocatechin-3-gallate attenuates microglial inflammation and neurotoxicity by suppressing the activation of canonical and noncanonical inflammasome via TLR4/NF-κB pathway. Mol Nutr Food Res 2019;63(21):e1801230.
    41 Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009;27:229-265.
    42 Deane R, Singh I, Sagare AP, Bell RD, Ross NT, LaRue B, Love R, Perry S, Paquette N, Deane RJ, Thiyagarajan M, Zarcone T, Fritz G, Friedman AE, Miller BL, Zlokovic BV. A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease. J Clin Invest 2012;122(4):1377-1392.
    43 Sakamoto K, Mizuta A, Fujimura K, Kurauchi Y, Mori A, Nakahara T, Ishii K. High-mobility group Box-1 is involved in NMDA-induced retinal injury the in rat retina. Exp Eye Res 2015;137:63-70.
    44 Shen JY, Ghai K, Sompol P, Liu X, Cao XB, Iuvone PM, Ye KQ. N-acetyl serotonin derivatives as potent neuroprotectants for retinas. Proc Natl Acad Sci U S A 2012;109(9):3540-3545.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Yu-Ze Zhao, Xue-Ning Zhang, Yi Yin,/et al.N-acetylserotonin alleviates retinal ischemia-reperfusion injury via HMGB1/RAGE/NF-κB pathway in rats. Int J Ophthalmol, 2024,17(2):228-238

Copy
Share
Article Metrics
  • Abstract:148
  • PDF: 845
  • HTML: 0
  • Cited by: 0
Publication History
  • Received:August 13,2023
  • Revised:November 07,2023
  • Online: January 22,2024